Preclinical evaluation and phase I clinical trial of a 99mTc-labeled synthetic polymer used in blood pool imaging

American Journal of Roentgenology

Volumn 171, Issue 1, 1998, Pages 137-143

  Callahan, Ronald J ^a   Bogdanov Jr , Alexei ^a   Fischman, Alan J ^a   Brady, Thomas J ^a   Weissleder, Ralph ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(O MONOMETHOXYPOLY(ETHYLENE GLYCOL) O' SUCCINYL)POLY(N EPSILON L LYSYL(TC 99M)DIETHYLENETRIAMINE PENTAACETATE MONOAMIDE; PENTETATE TECHNETIUM TC 99M; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DISTRIBUTION; DRUG SCREENING; DRUG SYNTHESIS; ELECTROCARDIOGRAM; FEMALE; FLUSHING; HEART PALPITATION; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RABBIT; RAT; TOXICITY TESTING;

EID: 0031859906     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.171.1.9648777     Document Type: Article

References (34)

1. Strauss H, Zaret B, Hurley P, et al. A scintigraphic method for measuring left ventricular ejection fraction in man without cardiac catheterization. Am J Cardiol 1971;28:575-580
2. Prince M. Body MR angiography with gadolinium contrast agents. Magn Reson Imaging Clin N Am 1996;4:11-24
3. Miskowiak J, Nielsen SL, Munck O. Scintigraphic diagnosis of gastrointestinal bleeding with 99mTc-labeled blood-pool agents. Radiology 1981;141: 499-504
4. Alavi A, Dann RW, Baum S, Biery DN. Scintigraphic detection of acute gastrointestinal bleeding. Radiology 1977;124:753-756
5. Callahan R, Froelich J, McKusick K, et al. A modified method for the in vivo labeling of red blood cells with Tc-99m. J Nucl Med 1982;23:315-318
6. Smith T, Richards P. A simple kit for the preparation of Tc-99m red blood cells. J Nucl Med 1976;17:126-132
7. Pavel D, Zimmer Z, Patterson V. In vivo labeling of red blood cells with Tc-99m: a new approach to blood pool visualization. J Nucl Med 1977;18:305-308
8. Srivistava S, Babich J, Richards P. A new kit method for the selective labeling of erythrocytes in whole blood with Tc-99m. J Nucl Med 1983;24:218
9. Sprandel U, Lanz D, Von Horsten W. Magnetically responsive erythrocyte ghosts. Methods Enzymol 1987;149:301-312
10. Goins B, Phillips W, Klipper R. Blood pool imaging using technetium-99m labeled liposomes. J Nucl Med 1996;37:1374-1379
11. Nishimura T, Hamada S, Hayashida K, Uehara T, Katabuchi T, Hayashi M. Cardiac blood-pool scintigraphy using technetium-99m MOEG-HSA: comparison with in vivo technetium-99m RBC labeling. J Nucl Med 1989;30:1713-1717
12. Thrall J, Freitas J, Swanson D, et al. Clinical comparison of cardiac blood pool visualization with technetium-99m red blood cells labeled in vivo and technetium-99m human serum albumin. J Nucl Med 1978;19:796-803
13. Atkins H, Srivistava S, Meinken G, Richards P. Biological behavior of erythrocytes labeled in vivo and in vitro with technetium-99m. J Nucl Med Technol 1985;13:136-139
14. Vanbilloen H, Verbeke K, De Roo M, Verbruggen A. Technetium-99m labelled human serum albumin for ventriculography: a comparative evaluation of six labelling kits. Eur J Nucl Med 1993;20:465-472
15. Callahan R, Chilton M. Radiopharmaceuticals for cardiac imaging. In: Guiberteau MJ, ed. Nuclear cardiovascular imaging: current clinical practice. New York: Churchill Livingstone, 1994:23-39
16. Verbeke K, Vanbilloen H, De Roo M, Verbruggen A. Technetium-99m mercaptoalbumin as a potential substitute for technetium-99m labeled red blood cells. Eur J Nucl Med 1993;20:473-482
17. Bogdanov A Jr, Callahan R, Wilkinson R, et al. A synthetic copolymer kit for radionuclide blood pool imaging. J Nucl Med 1994;35:1880-1886
18. Bogdanov AJ, Weissleder R, Frank H, et al. A new macromolecule as a contrast agent for MR angiography: preparation, properties and animal studies. Radiology 1993;187:701-706
19. Bogdanov A Jr, Martin C, Bogdanova A, Brady T, Weissleder R. An adduct of cis-diamminedichloroplatinum(II) and poly(ethylene glycol)poly(l-lysine)-succinate: synthesis and cytotoxic properties. Bioconjug Chem 1996;7:144-149
20. Staros JV, Wright RW, Swingle DM. Enhancement by N-hydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling reactions. Anal Biochem 1986;156:220-222
21. Robbins PJ. Chromatography of technetium-99m radiopharmaceuticals: a practical guide. Reston, VA: Society of Nuclear Medicine, 1984:11-33
22. Loevinger R, Berman M. A schema for absorbed dose calculations for biologically distributed radionuclides. J Nucl Med 1968;[suppl 2]:7-14
23. Stabin M. MIRDOSE: personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 1996;37:538-546
24. Bogdanov A, Wright SC, Marecos E, et al. A long-circulating co-polymer in "passive targeting" to solid tumors. J Drug Target 1997;4:321-330
25. Zalipsky S, Seltzer R, Menon-Rudolph S. Evaluation of a new reagent for covalent attachment of polyethylene glycol to proteins. Biotechnol Appl Biochem 1992;15:100-114
26. Smyth H, Carpenter C, Shaffer C. The toxicity of high molecular weight poly(ethylene glycols): chronic and parenteral administration. J Am Pharm Assoc 1947;36:157-160
27. Brady C, DiPalma JA, Morawski SG, Santa Ana CA, Fordtran JS. Urinary excretion of polyethylene glycol 3350 and sulfate after gut lavage with a polyethylene glycol electrolyte lavage solution. Gastroenterology 1986;90:1914-1918
28. Muss H, Spell N, Scudiery D, et al. A phase II trial of PEG-L-asparaginase in the treatment of non-Hodgkins lymphoma. Invest New Drugs 1990;8: 125-130
29. Ewel C, Urba W, Kopp W, et al. Polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose in combination with interleukin 2 in patients with cancer: clinical and immunological effects. Cancer Res 1992;52:3005-3010
30. Levine A, Sivulich M, Wiernik P, Levy H. Initial clinical trials in cancer patients of polyriboinosinic-polyribocytidylic acid stabilized with poly-L-lysine, in carboxymethylcellulose [poly(ICLC)], a highly effective interferon inducer. Cancer Res 1979;39:1645-1650
31. Abuchowski A, van Es T, Palczuk NC, Davis F. Alteration of immunological properties of bovine serum albumin by covalent attachment of poly(ethylene glycol). J Biol Chem 1977;252:3578-3581
32. Jain R. Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Cancer Metastasis Rev 1990;9:253-266
33. Gupta H, Weissleder R, Bogdanov AJ, Brady T. Detection of experimental hemorrhage by contrast enhanced MRI and comparison with scintigraphy. Radiology 1995;196:239-244
34. Gupta H, Wilkinson R, Bogdanov AJ, Callahan R, Weissleder R. Inflammation imaging: use of a long circulating graft copolymer (methoxypoly-(ethylene glycol) ethylene triamino pentaacetic acid). Radiology 1995;197:665-669